These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22959966)

  • 41. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
    Pierce RC; Rebec GV
    Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
    Desvignes C; Bert L; Vinet L; Denoroy L; Renaud B; Lambás-Señas L
    Neurosci Lett; 1999 Feb; 261(3):175-8. PubMed ID: 10081977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats.
    Nash JF; Yamamoto BK
    Brain Res; 1993 Nov; 627(1):1-8. PubMed ID: 7904885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of nitrogen narcosis on extracellular levels of dopamine and its metabolites in the rat striatum, using intracerebral microdialysis.
    Barthelemy-Requin M; Semelin P; Risso JJ
    Brain Res; 1994 Dec; 667(1):1-5. PubMed ID: 7895072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
    Gołembiowska K; Dziubina A
    Neurotox Res; 2012 Aug; 22(2):150-7. PubMed ID: 22407500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of sufentanil on the release and metabolism of dopamine and ascorbic acid and glutamate release in the striatum of freely moving rats.
    Serra PA; Susini G; Rocchitta G; Migheli R; Dessanti G; Miele E; Desole MS; Miele M
    Neurosci Lett; 2003 Jun; 344(1):9-12. PubMed ID: 12781909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presynaptic glutamate receptors facilitate release of norepinephrine and 5-hydroxytryptamine as well as dopamine in the normal and ischemic striatum.
    Ohta K; Fukuuchi Y; Shimazu K; Komatsumoto S; Ichijo M; Araki N; Shibata M
    J Auton Nerv Syst; 1994 Sep; 49 Suppl():S195-202. PubMed ID: 7836679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.
    Globus MY; Busto R; Dietrich WD; Martinez E; Valdes I; Ginsberg MD
    J Neurochem; 1988 Nov; 51(5):1455-64. PubMed ID: 2902196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of temperature with thiopental and etomidate on extracellular dopamine and glutamate levels in Wistar-Kyoto rats subjected to forebrain ischemia.
    Lesser JB; Koorn R; Vloka JD; Kuroda MM; Thys DM
    Acta Anaesthesiol Scand; 1999 Nov; 43(10):989-98. PubMed ID: 10593460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lactic acid-induced increase of extracellular dopamine measured by microdialysis in rat striatum: evidence for glutamatergic and oxidative mechanisms.
    Remblier C; Pontcharraud R; Tallineau C; Piriou A; Huguet F
    Brain Res; 1999 Aug; 837(1-2):22-8. PubMed ID: 10433984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat.
    Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Mura MA; De Natale G; Miele E; Miele M
    Brain Res; 1996 Jun; 723(1-2):154-61. PubMed ID: 8813393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: generalization across releasing mechanisms.
    Holson RR; Gazzara RA; Gough B
    Brain Res; 1998 Oct; 808(2):182-9. PubMed ID: 9767162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats.
    Gainetdinov RR; Grekhova TV; Sotnikova TD; Rayevsky KS
    Eur J Pharmacol; 1994 Aug; 261(3):327-31. PubMed ID: 7813556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glutathione deficiency potentiates manganese toxicity in rat striatum and brainstem and in PC12 cells.
    Desole MS; Esposito G; Migheli R; Sircana S; Delogu MR; Fresu L; Miele M; de Natale G; Miele E
    Pharmacol Res; 1997 Oct; 36(4):285-92. PubMed ID: 9425617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of ethanol on extracellular dopamine in rat striatum by direct perfusion with microdialysis.
    Yim HJ; Schallert T; Randall PK; Bungay PM; Gonzales RA
    J Neurochem; 1997 Apr; 68(4):1527-33. PubMed ID: 9084423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigations into the relationship between the dopaminergic system and ascorbic acid in rat striatum.
    Desole MS; Miele M; Enrico P; Esposito G; Fresu L; De Natale G; Miele E
    Neurosci Lett; 1991 Jun; 127(1):34-8. PubMed ID: 1881615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    J Neurochem; 2004 Feb; 88(4):1003-9. PubMed ID: 14756822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of long-term haloperidol treatment on glutamate-evoked ascorbate release in rat striatum.
    Teagarden MA; Rebec GV
    Eur J Pharmacol; 2001 Apr; 418(3):213-6. PubMed ID: 11343692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracellular ascorbate modulates glutamate dynamics: role of behavioral activation.
    Sandstrom MI; Rebec GV
    BMC Neurosci; 2007 May; 8():32. PubMed ID: 17506898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms.
    Pierce RC; Rebec GV
    J Neurosci; 1993 Oct; 13(10):4272-80. PubMed ID: 8105039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.